Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99per week for the first 24weeks
Just $1.99per week for the first 24weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

Health workers administer AstraZeneca COVID-19 vaccines in Ede, the Netherlands, on March 20, 2021.

PIROSCHKA VAN DE WOUW/AFP/Getty Images

Britain on Monday demanded the European Union allow the delivery of COVID-19 vaccines it has ordered as tensions over a possible export ban on EU-manufactured shots mounted and Brussels pointed an accusing finger at drugmaker AstraZeneca.

“The UK is not to blame. The EU is not to blame,” said an EU official. “It’s about everyone finding agreement with a company that has been over-selling its production capacity.”

After falling far behind post-Brexit Britain and the United States in rolling out vaccines, EU leaders are due to discuss a possible ban on vaccine exports to Britain at a summit on Thursday.

Story continues below advertisement

British Prime Minister Boris Johnson spoke on Sunday to the EU’s most powerful leaders, German Chancellor Angela Merkel and French President Emmanuel Macron, to steer them away from bans.

Johnson’s spokesman declined to comment on whether Britain, which exited the 27-nation EU’s orbit on Dec. 31, was considering retaliatory measures.

“I am not going to get into hypotheticals but our position is clear is that we do not want to see countries placing export restrictions on vaccinations,” he said.

AstraZeneca has told Brussels that the UK is using a clause in its supply contract that prevents exports of its vaccines until the British market is fully served, EU officials said.

The European Commission, which has coordinated vaccine orders for the EU, said reciprocity was key. The EU has exported some 35 million doses since the end of January, including 10 million to Britain, but Britain has exported none, even though two UK facilities feature in the EU’s contract with AstraZeneca.

The EU executive sent a letter of formal notice to the company last week, the first step in a dispute procedure.

“What our position is, is that we expect AstraZeneca to deliver the doses to the European Union that have been contracted. Contacts are ongoing with the company,” chief Commission spokesman Eric Mamer told a news conference.

Story continues below advertisement

He said the EU was also in talks with Britain on the issue, but did not give further details.

FRANCE, GERMANY, ITALY SUPPORT CURBS

While France, Germany and Italy broadly support tighter export curbs on those who do not reciprocate, countries including the Netherlands, Belgium and Ireland are more cautious about cutting off the UK.

Irish Prime Minister Michael Martin said any EU restrictions on vaccine exports would be a “retrograde step”.

German government spokeswoman Martina Fietz said Berlin favoured reviewing EU rules on vaccine exports because “a lot of vaccine is sent from the EU to third countries” but “virtually nothing is exported from Britain or the United States”.

The EU has so far blocked one shipment of vaccines to Australia.

An EU official told Reuters on Sunday that the bloc was rebuffing British government calls to ship AstraZeneca COVID-19 vaccines produced in a factory in the Netherlands, although the company has not made a formal export request.

Story continues below advertisement

“The Brits are insisting that the Halix plant in the Netherlands must deliver the drug substance produced there to them. That doesn’t work,” the official told Reuters.

The Leiden-based plant, run by sub-contractor Halix, is listed as a supplier of vaccines in both the contracts that AstraZeneca has signed with Britain and with the European Union.

AstraZeneca has not yet sought approval for vaccines produced at Halix to be used in the EU, but EU officials said the request was on its way.

As of March 20, the UK had administered nearly 44 vaccines for every 100 people, whereas the EU had administered nearly 13 shots per 100 people, according to public data compiled by Our World In Data website.

Our Morning Update and Evening Update newsletters are written by Globe editors, giving you a concise summary of the day’s most important headlines. Sign up today.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies